Applied DNA Sciences Inc (APDN)

[JLH2]

From my perspective, the DLA, MDA, NASA, JPL etc. are all very important in validating our technology for marking many different surfaces. But I still believe that the long term revenue is peanuts - the value is validation of the works and the additional patents generated from the works.

The branch of the govt that I want to see validate the technology is the FDA. With this APDN will start supplying mass producers of higher value products. A $25K or $50K fee for generating a mark is peanuts when you are marking millions of packages. This ends up costing the consumer $0.25 to $0.28 per prescription/bottle/package/etc. and generates a huge amount of revenue for APDN.

Then, there are all the other verticals that are being worked on.

The work for the additional FSG's only extends APDN's capability to enter into additional verticals down the road.